Luzzio; Michael J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Luzzio; Michael J..The latest application filed is for "ask1 inhibiting agents".
- Luzzio; Michael J. - Groton CT
- Luzzio; Michael J. - Noank CT
- Luzzio, Michael J - Noank CT
- Luzzio; Michael J. - Durham NC
| Patent | Date |
|---|---|
| ASK1 inhibiting agents Grant 11,168,095 - Gonzalez Lopez de Turiso , et al. November 9, 2 | 2021-11-09 |
| Ask1 Inhibiting Agents App 20190359634 - Gonzalez Lopez de Turiso; Felix ; et al. | 2019-11-28 |
| Sulfonyl amide derivatives for the treatment of abnormal cell growth Grant 10,450,297 - Luzzio , et al. Oc | 2019-10-22 |
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20190047979 - Luzzio; Michael J. ; et al. | 2019-02-14 |
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20170327485 - Luzzio; Michael J. ; et al. | 2017-11-16 |
| Pyrrolopyrimidine compounds as inhibitors of CDK4/6 Grant 8,957,074 - Brain , et al. February 17, 2 | 2015-02-17 |
| Pyrrolopyrimidine Compounds As Inhibitors Of Cdk4/6 App 20130150342 - Brain; Christopher Thomas ; et al. | 2013-06-13 |
| Methods for Augmenting Bone App 20090118316 - Olson; Lisa M. ; et al. | 2009-05-07 |
| Substituted oxindole derivatives as tyrosine kinase inhibitors Grant 7,071,217 - Dickerson , et al. July 4, 2 | 2006-07-04 |
| Benzimidazole derivatives useful as antiproliferative agents Grant 7,019,147 - Barth , et al. March 28, 2 | 2006-03-28 |
| Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents Grant 6,995,171 - Autry , et al. February 7, 2 | 2006-02-07 |
| Substituted oxindole derivatives as tyrosine kinase inhibitors App 20050228025 - Dickerson, Scott Howard ; et al. | 2005-10-13 |
| Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents App 20040171590 - Autry, Christopher ; et al. | 2004-09-02 |
| Substituted oxindole derivatives as tyrosine kinase inhibitors App 20030195234 - Dickerson, Scott Howard ; et al. | 2003-10-16 |
| Antitumor compounds Grant 5,126,351 - Luzzio , et al. June 30, 1 | 1992-06-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 